Suppr超能文献

肾造瘘管在无法治愈的恶性肿瘤所致输尿管梗阻中的应用。

Use of nephrostomy tubes in ureteric obstruction from incurable malignancy.

作者信息

Little B, Ho K J, Gawley S, Young M

机构信息

Department of Urology, Craigavon Area Hospital, Craigavon, Co Armagh.

出版信息

Int J Clin Pract. 2003 Apr;57(3):180-1.

Abstract

Malignancy may produce ureteric obstruction. This obstruction may be relieved by inserting a nephrostomy tube. All 31 cases of malignant ureteric obstruction from a single institution were retrospectively analysed. The commonest indications for nephrostomy tube insertion were renal failure (87%) and flank pain with hydronephrosis (13%). The mean serum creatinine levels pre and post insertion were 481 and 170 micromol/l, representing significant improvement (p<0.01). The complication rate was 13%, relating to tube blockage or dislodgement. Survival of patients was significantly worse if their malignancy was not resectable or suitable for chemotherapy (p=0.01). However, incurable patients still survived for a mean of 232 days, and although 46% of this time was spent as an inpatient, it did not differ significantly from the inpatient rate of curable patients (31%, p=0.1). Nephrostomy tube insertion should be considered for all palliative cases of malignant ureteric obstruction.

摘要

恶性肿瘤可能导致输尿管梗阻。插入肾造瘘管可缓解这种梗阻。对来自单一机构的31例恶性输尿管梗阻病例进行了回顾性分析。插入肾造瘘管最常见的指征是肾衰竭(87%)和伴有肾积水的胁腹痛(13%)。插入前后的平均血清肌酐水平分别为481和170微摩尔/升,有显著改善(p<0.01)。并发症发生率为13%,与导管堵塞或移位有关。如果恶性肿瘤不可切除或不适合化疗,患者的生存率明显更差(p=0.01)。然而,无法治愈的患者平均仍存活232天,尽管其中46%的时间是住院时间,但与可治愈患者的住院率(31%,p=0.1)相比,差异无统计学意义。对于所有恶性输尿管梗阻的姑息性病例,都应考虑插入肾造瘘管。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验